Scientific Industries, Inc.

Scientific Industries, Inc.

SCND
Scientific Industries, Inc.US flagOther OTC
0.75
USD
- -
- -
8.89MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
5.34
4.9
5.31
6.45
5.47
5.68
6.83
5.14
3.06
1.72
1.1
0.46
0.45
0.56
Basic EPS, GAAP
0.3
-0.05
0.01
0.11
-0.05
-0.11
0.43
-0.46
-1.15
-2.06
-0.9
-0.61
-0.11
-0.09
Free Cash Flow per Basic Share
0.41
0.02
0.1
0.58
0.02
0.17
0.76
-0.13
-1.14
-0.79
-0.61
-0.29
-0.72
-0.65
Dividend per Share
0.03
0.08
- -
- -
0.03
- -
0.05
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
2.61
2.39
2.25
2.34
2.26
2.15
2.54
2.09
-0.1
-2.1
-2.66
-3.18
-3.05
-3.07
Tangible Book Value per Share
3.02
2.29
2.43
2.91
3.05
3.12
3.65
7.48
6.04
2.31
1.23
0.79
0.92
0.76
Basic Weighted Avg Shares
1
1
1
1
1
1
1
2
3
7
10
11
11
12
Sales/Revenue/Turnover
7
7
8
10
8
8
10
8
10
11
11
5
5
7
Operating Margin (%)
7.11
-1.75
-0.21
4.77
-1.38
-0.06
7.61
-8.52
-48.17
-63.72
-83.34
-171.28
-150.35
-104.73
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
1
-1
-4
-14
-9
-6
-1
-1
Effective Tax Rate (%)
23.89
- -
- -
24.35
- -
11,564.29
16.18
- -
- -
- -
- -
- -
- -
0.38
Profit Margin (%)
5.56
-1.11
0.11
1.73
-0.89
-1.89
6.33
-9.03
-37.57
-119.89
-81.78
-134.36
-24.15
-15.64
Working Capital
4
3
3
4
4
4
5
11
16
14
11
7
9
8
LT Debt
- -
- -
- -
- -
- -
- -
- -
1
- -
1
1
1
1
1
Total Equity
5
6
6
6
6
6
6
12
26
18
14
9
11
9
Return on Invested Capital (%)
7.22
- -
- -
5.83
- -
10.94
10.7
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
11.59
- -
- -
5.45
- -
-10.78
18.08
- -
- -
- -
- -
- -
- -
3.98
Return on Common Equity (%)
11.98
-2.22
0.26
4.87
-2.12
-4.88
18.42
-20.19
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
8
6
9

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
12
10
9
Cash, Cash Equivalents & STI
8
7
6
Accounts Receivable, Net
1
1
1
Inventories
2
1
2
Total Current Liabilities
2
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.77%
10.48%
16.93%
Free Cash Flow
336.08%
391.05%
167.54%
Net Income, GAAP
162.02%
110.14%
-81.07%
Sales/Revenue/Turnover
-0.39%
-2.36%
5.35%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
3
1
3
5
2025
1
2
1
2
5
2026
1
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.2
-0.12
-0.11
- -
-0.61
2025
-0.17
-0.13
0.34
- -
-0.11
2026
-0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Helena R. Santos
Full Time Employees
61
Sector
Technology
Industry
Hardware, Equipment & Parts
Address
80 Orville Drive Bohemia NY United States of America 11716
IPO Date
Apr 4, 1994
Business
Scientific Industries, Inc. develops, manufactures, and markets advanced bioprocessing systems, vision-based pill counting solutions, and precision weighing instruments across the globe. The company recently underwent a strategic refocus, divesting its legacy Genie division, which encompassed traditional benchtop laboratory equipment like vortex mixers, shakers, rotators, and magnetic stirrers, to concentrate on high-growth, AI-driven technological platforms. Its core offerings now include a robust pharmacy automation portfolio under the VIVID brand, featuring sophisticated vision-based pill counters, automated workstations, and a newly launched AI-powered prescription label documentation and verification feature, alongside the development of an industry-first machine learning pill library anticipated for early 2026. Additionally, Scientific Industries provides its Scientific Bioprocessing (SBI) DOTS platform, designed to digitize biomanufacturing through real-time monitoring with components such as disposable dissolved oxygen nanoparticle sensors, optical pH sensors, and automated liquid injection systems for cell growth quantification and feeding in shake flasks. The company's Torbal division maintains its range of precision weighing instruments, including pharmacy, laboratory, and industrial digital scales, moisture analyzers, and force gauges. These specialized products serve a diverse clientele including universities, hospitals, pharmaceutical companies, pharmacies, national laboratories, and medical device manufacturers, with a particular emphasis on empowering independent pharmacies through automation. Scientific Industries distributes its solutions directly, as well as through a network of laboratory equipment partners and online channels. Established in 1954, the company maintains its corporate headquarters in Bohemia, New York.

Company News

APIChat
  • Scientific Industries, Inc. (SCND) Shareholder/Analyst Call Prepared Remarks Transcript

  • Scientific Industries, Inc. (SCND) Q3 2025 Earnings Call Prepared Remarks Transcript

  • Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature

  • Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025

  • Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

  • Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025

  • Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025

  • Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation's affiliate Troemner, LLC

  • Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

  • Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2025

  • Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025

  • Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division

  • Scientific Industries to Host Fiscal Year 2024 Financial Results Investor Call on April 1, 2025

  • Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market

  • Scientific Industries, Inc. (SCND) Q3 2023 Earnings Call Transcript

  • Scientific Industries Reports Third Quarter 2024 Financial Results

  • Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024

  • Scientific Industries to Present at the Craig-Hallum Bioprocessing Conference on September 19, 2024

  • Scientific Industries Reports Second Quarter 2024 Results

  • Scientific Industries to Host Second Quarter 2024 Financial Results Investor Call on August 15, 2024